BAKGRUND
Start 2006
CarpoNovum grundas av två kolorektala kirurger Anders Grönberg, MD, PhD, ingenjör, och professor Henrik Thorlacius, MD, PhD
Pris 2006
CarpoNovum erhöll
Öhrlings Price Water House Coopers och LUIS Innovation priser
Pris 2007
CarpoNovum erhöll Skapa Development Award
Pris 2007
CarpoNovum fick priset för det mest framgångsrika företaget i Connect Sweden-nätverket
CE 2011
CARP®, tidigare version av
C-REX®, CE märktes
Utveckling 2011-2018
C-REX® utvecklades,
kliniska studier genomfördes i Sverige, Danmark och Kina.
CE 2019
CE märkning av C-REX® portfolio
Scandinavian CCS 2020
Ett nytt dotterbolag har bildats med fokus på klinisk verksamhet och kirurgisk utbildning
Clinical trial in Malmö,
Sweden 2023
Investigator initiated study successfully finalized, see article.
Anders Grönberg
Henrik Thorlacius
OM CARPONOVUM
CarpoNovum AB är ett svenskt företag som utvecklar, tillverkar och levererar en ny generation kirurgiska instrument för kolorektal kirurgi.
Företagets huvudkontor, egen FoU och tillverkningsanläggningar finns i Halmstad, Sverige.
Scandinavian Centre for Colorectal Surgery och är ett dotterföretag till CarpoNovum som bedriver kliniska aktiviteter.
STYRELSE
Otto Drakenberg
Styrelseordförande
​
Otto Drakenberg is a Stockholm based CEO and Board Chairman with extensive experience leading complex transformations in a range of industry sectors such as consumer goods, retail, consumer service and technology. Otto is the chairman of the board of Spendrups Brewery, Svegro and Sisjö Intressenter and was until 2022 Group CEO of Scandi Standard. His former operational roles include CEO of Carlsberg Sweden, Group CEO of the Nordic wine and liquor group Arcus, Chairman of the Board and leader of the reconstruction and sale of the retail chain Twilfit, Group CEO of Moment Group.
Lars Johansson
Styrelsemedlem
​
Lars Johansson Brings 30 years of experience from the medtech and pharmaceutical industry, including 13 years as General Manager for Johnson & Johnson in the Nordics. Lars has a track record of being an extraordinary leader and his experience covers all strategic and operational aspects of bringing innovative treatments to patients.
Björn Olsen
Styrelsemedlem
​
Björn Olsen Professor and Senior Consultant of Infectious Diseases since 2007 at Uppsala University and Academic Hospital. Olsen's scientific publication has (2022) according to Google Scholar over 15,000 citations and an h-index of 60. He is also an ornithologist and expert in bird-borne diseases, including bird flu. In 2010, he published the book "Pandemic". Olsen was the summer host 2006 and 2020 at one of the Swedish radio channels.
KLINISKA RÅDGIVARE
Anna Martling, prof.
Chair of Advisory Board
Clinical advisor
​
Anna Martling is a Professor of Surgery at Karolinska Institutet, Stockholm, Sweden. She defended her thesis on rectal cancer in 2003, became a board certified surgeon in 2004 and an associate professor of surgery in 2009. In 2014 Martling became full professor of surgery. Since 2019 she holds the position as Dean at Karolinska Institutet, Stockholm.
She is considered to be a world leading expert in her field and is a frequent lecturer in Sweden and abroad. Professor Martling is Honorary Fellow of Royal College of Surgeon of England, (FRCS), American Colleges of Surgeons (FACS) and American Society of Colorectal Surgeons (FASCRS). Professor Martling is chairman of the Swedish Colorectal Cancer Study Group, which is a national research network for colorectal cancer in Sweden. Professor Martling has received numerous awards for her research within the colorectal field and in 2023 she was appointed honorary member of the European Society of Coloproctology (ESCP) which is awarded to individuals who have made an outstanding contribution to the field of coloproctology.
​
Photo from Karolinska Institutet.
Torbjörn Holm, prof.
Klinisk rådgivare
​
Tidigare Professor i kirurgi vid Karolinska Institutet med specialisering inom kolorektalkirurgi. Torbjörn har starkt bidraget till utvecklingen av multidisciplinär kirurgisk behandling av avancerad kolorektalcancer i Sverige.
Dr. Amir Szold
Clinical Advisor
​​
Amir Szold is a senior surgeon who has worked with alternative anastomosis devices for many years, and an entrepreneur who has been involved in numerous medical device start-up companies that have been acquired by J&J, Stryker, STI, and Bard, among others. He is currently Chairman, co-founder and Medical Director of Assia Medical Group, and CMO and co-founder of Human Xtensions.
Dr. Michele Diana
Clinical Advisor
​​
Michele Diana is a surgeon and translational (“bench to bedside”) scientist in new surgical technologies, with expertise in medical device design and development. Research interests include image-guided surgery, surgical robotics and surgical applications of machine and deep learning. He has experience with alternative anastomosis methods, including experiments with magnetic anastomosis.
He is currently engaged in entrepreneurial ventures with the aim of closing the gap between academia and market.
Matt McKittrick
Regulatory Advisor
​​
Matt McKittrick is a medical device executive with years of experience leading marketing, sales, product management and revenue generation strategies for companies such as Momentis Surgical, CytoVeris Inc., Stryker, Novadaq Technologies and Olympus America. Matt is currently VP of Sales and Marketing at Activ Surgical, a leader in advanced imaging techniques in surgical applications.
Will Rutan
Regulatory Advisor
​​
Will Rutan is an accomplished start-up executive in the medical device industry. He has a proven track record in steering regulatory approval processes, and is an expert in strategic positioning, fundraising, marketing and sales strategies, design and development oversight, and market penetration strategies.
FINANCIAL ADVISORY BOARD
Johan Stein
Finansiell rådgivare
​
Lärare och forskare vid Handelshögskolan i Stockholm under 12 år. Johan tog en doktorsexamen 1993 och blev senare utnämnd till docent och tf professor. Har varit analyschef och aktiechef vid Nordea Investment Management. Har också erfarenhet från Alfred Berg och BNP Paribas.
Christophe Genetay
Finansiell rådgivare
​
M.Sc. Civ Eng. med 25 års erfarenhet inom finansbranschen och arbete med börsnoterade och onoterade företag. Tidigare utbildningschef på Sveriges Aktiesparares Riksförbund. Sedan 2013 har Christophe varit engagerad i Investor Relations i olika branscher.
K&R
Kvalitet & Regulatorisk
C-REX® är CE märkt i enlighet med Medical Device Directive 93/42/EC, klass IIa.
CarpoNovum är certifierade i enlighet med EN ISO 13485.
Kvalitetspolicy
Alla teammedlemmar i CarpoNovum vill bidra till att förbättra liv för människor som genomgår kolorektal kirurgi, genom att tillhandahålla högkvalitativa, säkra, effektiva produkter och tjänster som uppfyller våra kunders behov, med fokus på ständig förbättring, genom att:
-
ha ett nära samarbete med ledande kirurger och vårdpersonal
-
följa alla tillämpliga regulatoriska krav
-
ständigt förbättra effektiviteten i vårt kvalitetsstyrningssystem
-
regelbundet granska prestanda för kvalitetsstyrningssystemet och våra kvalitetsmål
-
kommunicera denna kvalitetspolicy till alla teammedlemmar, underleverantörer och leverantörer för att försäkra att den förstås och genomförs
​
​